$9M Shaved From Novartis Jaw Injury Award By NY Judge
A New York judge on Wednesday denied Novartis Pharmaceuticals Corp.'s bid for a mistrial declaration in litigation over jaw deterioration injuries purportedly linked to bone drug Zometa, but slashed a $10...To view the full article, register now.
Already a subscriber? Click here to view full article